Showing 6531-6540 of 10618 results for "".
- Advances in Gastrointestinal Surgical Innovations: Bridging Technology and Safetyhttps://reachmd.com/news/advances-in-gastrointestinal-surgical-innovations-bridging-technology-and-safety/2483324/The technique of laparoscopic gastric bypass not only minimizes operative trauma but also enhances recovery, improving both initial and long-term patient outcomes, as demonstrated in a recent
- Compromised Breaths: The Legacy of Passive Smoking in Pediatric Healthhttps://reachmd.com/news/compromised-breaths-the-legacy-of-passive-smoking-in-pediatric-health/2483219/Secondhand smoke (SHS) poses lasting risks for children, with emerging research suggesting possible intergenerational associations linked to paternal exposures. This ex
- Revolutionizing Asthma Care: The Role of Molecular Allergy Chips in Precision Diagnosishttps://reachmd.com/news/revolutionizing-asthma-care-the-role-of-molecular-allergy-chips-in-precision-diagnosis/2483191/Asthma, with its unpredictability and varied manifestations, continues to perplex healthcare providers in their pursuit of precise interventions. At the forefront of this challenge, molecular allergy chips are reshaping diagnostic landscapes, leading us toward a future of truly pers
- Aquablation Therapy: A Surgical Innovation in BPH Treatmenthttps://reachmd.com/news/aquablation-therapy-a-surgical-innovation-in-bph-treatment/2483114/The field of urology is witnessing transformative changes with the integration of Aquablation therapy in the management of benign prostatic hyperplasia (BPH). This innovative approach is redefining precision and, in clinical trials and selected patients, has been associated with shorter cat
- Innovations and Legislation in Fibromyalgia Treatment: A New Erahttps://reachmd.com/news/innovations-and-legislation-in-fibromyalgia-treatment-a-new-era/2483091/Recent scientific advances and targeted policy efforts are shaping a cautious but meaningful shift in fibromyalgia care for the many people living with chronic, widespread pain.
- Uncovering Dermatology's Spectrum: Lebrikizumab's Promise in Skin of Colorhttps://reachmd.com/news/uncovering-dermatologys-spectrum-lebrikizumabs-promise-in-skin-of-color/2483099/Atopic dermatitis (AD) represents a common dermatological challenge, particularly in skin of color, where its presentation and treatment efficacy can diverge significantly, a nuance acknowledged in major dermatology guidelines and consensus statements. Addressing this evidence gap re
- Revolutionizing Cancer Care: From Genetic Diagnostics to Innovative Therapieshttps://reachmd.com/news/revolutionizing-cancer-care-from-genetic-diagnostics-to-innovative-therapies/2483073/Oncology is steadily shifting toward less invasive detection and more tailored treatment, while clinicians are balancing enthusiasm for new tools with the evidence needed to change practice. Across modalities—from liquid biopsy to mutation mapping to imaging—teams are testing how earlier, r
- Suzetrigine and Novel Biomarkers: Shaping the Future of Non-Opioid Pain Managementhttps://reachmd.com/news/suzetrigine-and-novel-biomarkers-shaping-the-future-of-non-opioid-pain-management/2483048/In the midst of an opioid crisis, new avenues for pain management are proving critical. Suzetrigine emerges as a promising non-opioid option for acute pain, with potential to reduce opioid exposure and associated misuse risk. The unique mechanism of Suzetrigine, a selective NaV1.8 so
- Immune Checkpoint Inhibitors and the Future of Cancer Treatmenthttps://reachmd.com/news/immune-checkpoint-inhibitors-and-the-future-of-cancer-treatment/2483019/Immune checkpoint inhibitors have revolutionized cancer treatment by re‑engaging the body's immune response, offering new hope in challenging cases such as small cell lung cancer (SCLC). For extensive‑stage SCLC, adding atezolizumab or durvalumab to platinum–etoposide is now a first‑line st
- The Promise of Autologous Cartilage Cells in Hip Surgeryhttps://reachmd.com/news/revolutionizing-hip-surgery-the-promise-of-autologous-cartilage-cells/2483022/Autologous cartilage cell approaches are being investigated for hip repair and may personalize care; while early results are encouraging, definitive guidelines and long‑term outcome data are still evolving. The integration of a patient’s own cartilage cells—specifically autologous ch